Somewhat Positive Media Coverage Somewhat Unlikely to Affect Neuberger Berman High Yield Strateges Fd (NHS) Share Price

Media stories about Neuberger Berman High Yield Strateges Fd (NYSE:NHS) have trended somewhat positive recently, Accern reports. The research group identifies positive and negative press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Neuberger Berman High Yield Strateges Fd earned a coverage optimism score of 0.25 on Accern’s scale. Accern also gave news coverage about the investment management company an impact score of 48.0770691063571 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Neuberger Berman High Yield Strateges Fd (NYSE NHS) opened at 12.09 on Thursday. Neuberger Berman High Yield Strateges Fd has a 12 month low of $10.67 and a 12 month high of $12.21. The stock has a 50 day moving average of $11.97 and a 200-day moving average of $11.91.

The business also recently disclosed a monthly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 15th will be paid a dividend of $0.0725 per share. This represents a $0.87 dividend on an annualized basis and a dividend yield of 7.20%. The ex-dividend date is Thursday, September 14th.

In other news, insider Thomas P. Oreilly sold 14,000 shares of the stock in a transaction that occurred on Wednesday, August 9th. The stock was sold at an average price of $12.08, for a total transaction of $169,120.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Thomas P. Oreilly sold 4,000 shares of the firm’s stock in a transaction on Thursday, August 10th. The stock was sold at an average price of $11.83, for a total value of $47,320.00. The disclosure for this sale can be found here.

COPYRIGHT VIOLATION NOTICE: This piece was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://stocknewstimes.com/2017/09/28/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-neuberger-berman-high-yield-strateges-fd-nhs-share-price.html.

About Neuberger Berman High Yield Strateges Fd

Neuberger Berman High Yield Strategies Fund Inc is a non-diversified, closed-end management investment company. The Fund seeks total return (income plus capital appreciation). The Fund normally invests at least 80% of its total assets in high yield debt securities of the United States and foreign issuers, which include securities that are rated below investment grade by a rating agency or are unrated debt securities determined to be of comparable quality by the Fund’s investment manager.

Insider Buying and Selling by Quarter for Neuberger Berman High Yield Strateges Fd (NYSE:NHS)

Receive News & Ratings for Neuberger Berman High Yield Strateges Fd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuberger Berman High Yield Strateges Fd and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply